Morphological Detection of Hormone and Growth Factor Receptors in Breast Cancer
作者： Konrad Kölble
DOI: 10.1007/978-3-540-46091-6_17
关键词: Bioinformatics 、 Hormone 、 Clinical Oncology 、 Clin oncol 、 Pathology 、 Growth factor receptor 、 Histopathology 、 Receptor 、 Breast cancer 、 Estrogen receptor 、 Biology
摘要: In the multidisciplinary effort of today's clinical oncology, histopathology has to deal increasingly with genetic and proteomic profiles neoplastic cells obtained in ever smaller samples via various diagnostic routes. None numerous molecular markers available surpassed hormone growth factor receptors their relevance for selection targeted therapies. following, morphologic concepts histopathologic methods pertinent clinically most important are discussed a focus on tumors breast.
springer.com
sci-hub.st 参考文章(35)
S. Roka, M. Rudas, S. Taucher, P. Dubsky, T. Bachleitner-Hofmann, D. Kandioler, M. Gnant, R. Jakesz, High nuclear grade and negative estrogen receptor are significant risk factors for recurrence in DCIS. Ejso. ,vol. 30, pp. 243- 247 ,(2004) , 10.1016/J.EJSO.2003.11.004
D. Slamon, G. Clark, S. Wong, W. Levin, A Ullrich, W. McGuire, Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science. ,vol. 235, pp. 177- 182 ,(1987) , 10.1126/SCIENCE.3798106
Michael J. Kerin, Valerie Speirs, David S. Walton, Peter J. Carleton, Stephen L. Atkin, Alicia T. Parkes, John N. Fox, Coexpression of estrogen receptor alpha and beta: poor prognostic factors in human breast cancer? Cancer Research. ,vol. 59, pp. 525- 528 ,(1999)
Meredith M. Regan, Giuseppe Viale, Mauro G. Mastropasqua, Eugenio Maiorano, Rastko Golouh, Antonino Carbone, Bob Brown, Mart Suurküla, Gerald Langman, Luca Mazzucchelli, Stephen Braye, Piergiovanni Grigolato, Richard D. Gelber, Monica Castiglione-Gertsch, Karen N. Price, Alan S. Coates, Aron Goldhirsch, Barry Gusterson, Re-evaluating Adjuvant Breast Cancer Trials: Assessing Hormone Receptor Status by Immunohistochemical Versus Extraction Assays Journal of the National Cancer Institute. ,vol. 98, pp. 1571- 1581 ,(2006) , 10.1093/JNCI/DJJ415
Michael F. Press, Guido Sauter, Leslie Bernstein, Ivonne E. Villalobos, Martina Mirlacher, Jian-Yuan Zhou, Rooba Wardeh, Yong-Tian Li, Roberta Guzman, Yanling Ma, Jane Sullivan-Halley, Angela Santiago, Jinha M. Park, Alessandro Riva, Dennis J. Slamon, Diagnostic Evaluation of HER-2 as a Molecular Target: An Assessment of Accuracy and Reproducibility of Laboratory Testing in Large, Prospective, Randomized Clinical Trials Clinical Cancer Research. ,vol. 11, pp. 6598- 6607 ,(2005) , 10.1158/1078-0432.CCR-05-0636
Chih-Yi Hsu, Donald Ming-Tak Ho, Ching-Fen Yang, Chiung-Ru Lai, I-Ting Yu, Hung Chiang, Interobserver reproducibility of Her-2/neu protein overexpression in invasive breast carcinoma using the DAKO HercepTest. American Journal of Clinical Pathology. ,vol. 118, pp. 693- 698 ,(2002) , 10.1309/6ANB-QXCF-EHKC-7UC7
Sietse Mosselman, Jan Polman, Rein Dijkema, ERβ: Identification and characterization of a novel human estrogen receptor FEBS Letters. ,vol. 392, pp. 49- 53 ,(1996) , 10.1016/0014-5793(96)00782-X
Anthony Rhodes, Bharat Jasani, Andre J. Balaton, Diana M. Barnes, Elizabeth Anderson, Lynda G. Bobrow, Keith D. Miller, Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of unreliable assays. American Journal of Clinical Pathology. ,vol. 115, pp. 44- 58 ,(2001) , 10.1309/H905-HYC1-6UQQ-981P
Michael F. Press, Dennis J. Slamon, Kerry J. Flom, Jinha Park, Jian-Yuan Zhou, Leslie Bernstein, Evaluation of HER-2/neu Gene Amplification and Overexpression: Comparison of Frequently Used Assay Methods in a Molecularly Characterized Cohort of Breast Cancer Specimens Journal of Clinical Oncology. ,vol. 20, pp. 3095- 3105 ,(2002) , 10.1200/JCO.2002.09.094
Jennet M. Harvey, Gary M. Clark, C. Kent Osborne, D. Craig Allred, Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer Journal of Clinical Oncology. ,vol. 17, pp. 1474- 1474 ,(1999) , 10.1200/JCO.1999.17.5.1474